Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance

• Priya BahriEuropean Medicines Agency
• Geoffrey BowringUppsala Monitoring Centre
• Brian David Edwards
• Christopher AntonBirmingham City Hospital
• Jeffrey K AronsonUniversity of Oxford
• Angela Caro-RojasPontificia Universidad Javeriana
• Bruce Hugman
• Peter G. M. MolUniversity of Groningen
• Gianluca TrifiròUniversity of Verona
• Katarina Ilić
• Riadh Daghfous
• Irene Fermont
• Giovanni FurlanPfizer (Italy)
• Wolfgang GaissmaierUniversity of Konstanz
• Mohammad Ishaq GeerUniversity of Kashmir
• Kenneth Y Hartigan-GoAteneo de Manila University
• François HouÿezEuropean Organisation for Rare Diseases
• Hansjörg NethUniversity of Konstanz
• Gediminas NorgelaUppsala Monitoring Centre
• Yaowares OppamayunFood and Drug Administration
• David Kenneth RaynorUniversity of Leeds
• Mehdi BouhlelUniversity of Monastir
• Federica SantoroUppsala Monitoring Centre
• Janet SultanaMater Dei Hospital